Silexion Therapeutics Corp (SLXN) stock
SLXNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as SLXNW
$1.44−0.21 (-12.73%)
Close on Nov 18, 2026Market cap $868.40KP/E –Yield –
Silexion Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Silexion Therapeutics's price to book ratio was 86.6× on Nov 11, 2026, against 72.6× a year earlier.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 86.6× | −119.9 |
| 2025 | Dec 31, 2025 | 206.5× | – |
See a number that looks wrong?